Literature DB >> 16271313

Psychological and cognitive effects of long-term peyote use among Native Americans.

John H Halpern1, Andrea R Sherwood, James I Hudson, Deborah Yurgelun-Todd, Harrison G Pope.   

Abstract

BACKGROUND: Hallucinogens are widely used, both by drug abusers and by peoples of traditional cultures who ingest these substances for religious or healing purposes. However, the long-term residual psychological and cognitive effects of hallucinogens remain poorly understood.
METHODS: We recruited three groups of Navajo Native Americans, age 18-45: 1) 61 Native American Church members who regularly ingested peyote, a hallucinogen-containing cactus; 2) 36 individuals with past alcohol dependence, but currently sober at least 2 months; and 3) 79 individuals reporting minimal use of peyote, alcohol, or other substances. We administered a screening interview, the Rand Mental Health Inventory (RMHI), and ten standard neuropsychological tests of memory and attentional/executive functions.
RESULTS: Compared to Navajos with minimal substance use, the peyote group showed no significant deficits on the RMHI or any neuropsychological measures, whereas the former alcoholic group showed significant deficits (p < .05) on every scale of the RMHI and on two neuropsychological measures. Within the peyote group, total lifetime peyote use was not significantly associated with neuropsychological performance.
CONCLUSIONS: We found no evidence of psychological or cognitive deficits among Native Americans using peyote regularly in a religious setting. It should be recognized, however, that these findings may not generalize to illicit hallucinogen users.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271313     DOI: 10.1016/j.biopsych.2005.06.038

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  20 in total

1.  Culture, psychosomatics and substance abuse: the example of body image drugs.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Psychother Psychosom       Date:  2012-01-18       Impact factor: 17.659

Review 2.  Human hallucinogen research: guidelines for safety.

Authors:  Mw Johnson; Wa Richards; Rr Griffiths
Journal:  J Psychopharmacol       Date:  2008-07-01       Impact factor: 4.153

Review 3.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 4.  Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions.

Authors:  Ricardo Jorge Dinis-Oliveira; Carolina Lança Pereira; Diana Dias da Silva
Journal:  Curr Mol Pharmacol       Date:  2019       Impact factor: 3.339

Review 5.  Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.

Authors:  David Bender; David J Hellerstein
Journal:  Psychopharmacology (Berl)       Date:  2022-01-13       Impact factor: 4.530

Review 6.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

7.  Examination of Recreational and Spiritual Peyote Use Among American Indian Youth.

Authors:  Mark A Prince; Maeve B O'Donnell; Linda R Stanley; Randall C Swaim
Journal:  J Stud Alcohol Drugs       Date:  2019-05       Impact factor: 2.582

8.  Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.

Authors:  Gabrielle Agin-Liebes; Trevor F Haas; Rafael Lancelotta; Malin V Uthaug; Johannes G Ramaekers; Alan K Davis
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-23

9.  Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study.

Authors:  José Carlos Bouso; Débora González; Sabela Fondevila; Marta Cutchet; Xavier Fernández; Paulo César Ribeiro Barbosa; Miguel Ángel Alcázar-Córcoles; Wladimyr Sena Araújo; Manel J Barbanoj; Josep Maria Fábregas; Jordi Riba
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

10.  Psychedelics and mental health: a population study.

Authors:  Teri S Krebs; Pål-Ørjan Johansen
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.